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It was a pleasure to read the report from Dunham and
coworkers [1] concerning the relationship between
hypocholesterolemia and outcome in patients following
severe trauma. Although their study involved only 28 patients,
these patients were severely injured (Injury Severity Score
31±9) and they required at least 7 days of mechanical
ventilation. Upon admission to the surgical intensive care unit
the mean cholesterol level was only 119±44mg/dl, as
compared with the expected normal cholesterol level (taken
from a database) of 201±17mg/dl (P<0.001). In the
patients who died (n=3), the final cholesterol values were
33% lower than their initial postinjury levels, whereas in
patients who survived the final cholesterol levels had risen by
28%. Interestingly, the initial postinjury levels were
considerably higher in the three patients who died than in
those who survived (175±62mg/dl versus 112±37mg/dl).
Although these results are impressive, it is unknown whether
the expected (preadmission) cholesterol values used as
control, which were acquired from the general population, are
consistent with those observed in the trauma population. It
would have been interesting to know the actual preadmission
cholesterol levels (obtained either retrospectively or through
follow-up evaluation); complete lipid profiles (e.g. triglycerides,
very-low-density lipoprotein, low-density lipoprotein [LDL],
high-density lipoprotein [HDL]), including how each was
individually affected; cytokine data (especially tumor necrosis
factor-α, IL-6) to correlate with cholesterol levels; and
nutritional status (especially lipid intake) of these patients.
Dunham and coworkers also noted a relationship between
cholesterol levels and infection. Cholesterol levels either
remained low or fell in 90% of patients presenting with an
infection. This response was more often associated with
infection than with traditional markers such as leukocyte
response, which was positive in only 61% of patients.
Cholesterol levels also decreased with the onset of each
organ system dysfunction (ratio of arterial oxygen tension to
fractional inspired oxygen <350, creatinine >2.0mg/dl,
glucose >120mg/dl, bilirubin >2.5mg/dl, arterial
bicarbonate ≥28 or ≤23mmol/l; P<0.01).
The findings of Dunham supplement the literature concerning
hypocholesterolemia and critical illness [2].
Hypocholesterolemia was first reported in 1911, when
Chauffard and coworkers reported decreased cholesterol
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Abstract
Hypocholesterolemia is an important observation following trauma. In a study of critically ill trauma
patients, mean cholesterol levels were significantly lower (119 ± 44 mg/dl) than expected values
(201 ± 17 mg/dl). In patients who died, final cholesterol levels fell by 33% versus a 28% increase in
survivors. Cholesterol levels were also adversely affected by infection or organ system dysfunction.
Other studies have illustrated the clinical significance of hypocholesterolemia. Because lipoproteins
can bind and neutralize lipopolysaccharide, hypocholesterolemia can negatively impact outcome. New
therapies directed at increasing low cholesterol levels may become important options for the treatment
of sepsis.
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levels in patients who were in ‘very bad general condition’
during the febrile phase of tuberculosis. In 1920, Kipp noted
a relationship between the degree of hypocholesterolemia
and the severity of infection. We were unable to identify other
articles about hypocholesterolemia following injury or
infection in the literature until 1980, when an article by
Coombes and coworkers [3] was published that described
the changes in lipoproteins after burn injury. Those
investigators observed a profound decrease in cholesterol
levels within a few days of the burn, with the lowest values
occurring between the days 6 and 10. They noted that both
LDL and HDL, which carry over 80% of the total cholesterol
in humans, were both decreased. In contrast, triglyceride-rich
very-low-density lipoproteins increased in the acute phase.
Of the various reasons offered for the hypocholesterolemia
seen in critically ill and injured patients, especially those with
sepsis, one that seems especially important is related to the
ability of lipids and lipoproteins to bind to and neutralize
bacterial endotoxin (lipopolysaccharide [LPS]) [4]. It has
been noted that LPS in blood binds to LPS binding protein
[5], activating the cell surface CD14 receptor [6]. This
stimulates the release of a cascade of proinflammatory
cytokines, including tumor necrosis factor-α, IL-1, and IL-6
[7]. If LPS binds to lipoproteins (e.g. cholesterol), then
cytokine release is decreased [8].
Animal experiments appear to corroborate this interaction.
For example, transgenic mice with elevated HDL [9] or LDL
concentrations [10] are protected against lethal endotoxemia
and severe Gram-negative infections. Indeed, infusion of HDL
blocked LPS-induced cytokine production in rabbits [11] and
protected against lethal doses of endotoxin in mice [9]. The
administration of HDL to human volunteers also blocks many
of the effects seen with infusion of LPS [12,13].
Clinical support was provided by Gordon and coworkers [14],
who recently (2001) reported low cholesterol and lipoprotein
concentrations in 111 critically ill surgical patients. They noted
that these levels correlated inversely with concentrations of
IL-6, soluble IL-2 receptor, and IL-10. The lowest cholesterol
and lipoprotein levels also predicted a poor clinical outcome.
Those investigators suggested that hypolipidemia
(hypocholesterolemia) is an independent predictor of clinical
outcome in critically ill patients. They also implied that a
vicious cycle is initiated in many critically ill patients with acute
sepsis with an increased production of inflammatory
cytokines, which then decreases lipid and lipoprotein
concentrations and increases the susceptibility to LPS.
Dunham and coworkers should be congratulated for their
contribution to this growing body of evidence and its
implications for future treatments. If there were a way to
increase the low lipid concentrations in these patients, then
this could be an important therapeutic option for preventing
and treating sepsis.
Competing interests
None declared.
References
1. Dunham CM, Fealk MH, Sever WE: Following severe injury,
hypocholesterolemia improves with convalescence but per-
sists with organ failure or onset of infection. Crit Care 2003, 7:
R145-R153.
2. Fraunberger P, Schaefer S, Werdan K, Walli AK, Seidel D:
Reduction of circulating cholesterol and apolipoprotein levels
during sepsis. Clin Chem Lab Med 1999, 37:357-362.
3. Coombes EJ, Shakespeare PG, Batstone GF: Lipoprotein
changes after burn injury in man. J Trauma 1980, 20:971-975.
4. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones
AL, Eichbaum EB, Bland GF, Rapp JH: Chylomicrons alter the
fate of endotoxin, decreasing tumor necrosis factor release
and preventing death. J Clin Invest 1993, 91:1028-1034.
5. Tobias PS, Soldau K, Ulevitch RJ: Identification of a lipid A
binding site in the acute phase reactant lipopolysaccharide
binding protein. J Biol Chem 1989, 264:10867-10871.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC:
CD14, a receptor for complexes of lipopolysaccharide (LPS)
and LPS binding protein. Science 1990, 249:1431-1433.
7. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD,
Mathison JC, Tobias PS, Ulevitch RJ: Structure and function of
lipopolysaccharide binding protein. Science 1990, 249:1429-
1431.
8. Baumberger C, Ulevitch RJ, Dayer JM: Modulation of endotoxic
activity of lipopolysaccharide by high-density lipoprotein.
Pathobiology 1991, 59:378-383.
9. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL: In vivo
protection against endotoxin by plasma high density lipopro-
tein. Proc Natl Acad Sci USA 1993, 90:12040-12044.
10. Netea MG, Demacker PN, Kullberg BJ, Boerman OC, Ver-
schueren I, Stalenhoef AF, van der Meer JW: Low-density
lipoprotein receptor-deficient mice are protected against
lethal endotoxemia and severe Gram-negative infections. J
Clin Invest 1996, 97:1366-1372.
11. Hubsch AP, Powell FS, Lerch PG, Doran JE: A reconstituted,
apolipoprotein A-I containing lipoprotein reduces tumor
necrosis factor release and attenuates shock in endotoxemic
rabbits. Circ Shock 1993; 4:14-23.
12. Pajkrt D, Lerch PG, van der Poll T, Levi M, Illi M, Doran JE, Arnet
B, van den Ende A, ten Cate JW, van Deventer SJ: Differential
effects of reconstituted high-density lipoprotein on coagula-
tion, fibrinolysis and platelet activation during human endo-
toxemia. Thromb Haemost 1997, 77:303-307.
13. Gordon BR, Parker TS, Levine DM, Saal SD, Wange JCL, Sloan
BJ, Barie PS, Rubin AL: Low lipid concentrations in critical
illness: Implications for preventing and treating endotoxemia.
Crit Care Med 1996, 24:584-589.
14. Gordon BR, Parker TS, Levine DM, Saal SD, Wange JCL, Sloan
BJ, Barie PS, Rubin AL: Relationship of hypolipidemia to
cytokine concentrations and outcomes in critically ill surgical
patients. Crit Care Med 2001, 29:1563-1568.